Dynamic Networks and Mechanisms of Allosteric Communication in Proteins

蛋白质变构通讯的动态网络和机制

• 批准号: 7933132
• 负责人: Andrew L Lee
• 金额: $ 9.76万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-30 至 2010-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7933132
• 关键词: Address; Allosteric Regulation; Behavior; Binding; Biological; Biological Process; Biology; Biotechnology; Cell division; Chemicals; Chemotaxis; Communication; Coupling; Data; Databases; Distal; Drug effect disorder; Drug resistance; Escherichia coli; Event; Fluorescence; Foundations; Free Energy; Funding; Goals; Heart; Heterogeneity; Individual; Industry; Lead; Ligand Binding; Ligands; Light; Maps; Measurement; Measures; Mediating; Metabolism; Methodology; Methods; Modeling; Modification; Motion; Motor; Mutation; Pathway interactions; Pattern; Peptides; Pharmaceutical Preparations; Phosphorylation; Play; Population Dynamics; Process; Property; Protein Dynamics; Proteins; Regulation; Relative (related person); Relaxation; Research; Role; Serine Proteinase Inhibitors; Side; Signal Pathway; Signal Transduction; Site; Solutions; Stimulus; Structure; Surface; Technology; Tertiary Protein Structure; Testing; Therapeutic; Therapeutic Intervention; Thermodynamics; Time; base; beryllium fluoride; density; design; drug discovery; engineering design; falls; genetic regulatory protein; globular protein; mutant; protein folding; protein function; public health relevance; research study; response; theories

DESCRIPTION (provided by applicant): How proteins regulate themselves is a fundamental question in biology. Regulation of protein activity drives cell division, metabolism, signal transduction, and therapeutic intervention. The most common and versatile regulatory proteins are allosteric proteins. Allosteric proteins are distinguished by their capacity to respond to ligand binding or chemical modification at one site, and alter ligand binding or activity at a distal site. Although many allosteric proteins have been characterized structurally, and models of allostery exist, most of the details of how allosteric transitions proceed remain unknown. The long-range goal of this research is to experimentally reveal the time-resolved structural processes that constitute allosteric function. Central to the approach to be taken is the idea that proteins are highly dynamic, especially allosteric proteins, and that dynamic motions are an essential component of allosteric conformational change. Classical oligomeric allosteric proteins are too large for in-depth studies of site-specific dynamics by NMR. Therefore, the monomeric, 14 kDa bacterial response regulator CheY protein will be used as a model allosteric domain. CheY is a chemotaxis signal transduction protein that, upon phosphorylation at Asp-57, undergoes a conformational change at a distal surface that modulates binding to the flagellar motor. The ps-ns and ¿s-ms timescale dynamics of CheY will be extensively characterized in the absence and presence of phosphoryl group mimic, BeF3-, using NMR relaxation methods. In separate experiments, long-range thermodynamic couplings will be mapped using high-throughput methodology. Because, recently, long-range communication has been observed in proteins that are not functionally allosteric, mechanisms similar to those in allosteric proteins may exist in non-allosteric proteins, albeit to a lesser extent. The serine protease inhibitor eglin c is a good example of this: conservative mutations in eglin c lead to long-range dynamic effects in the absence of structural change. In the proposed research, four Specific Aims fall into two main thrusts. In the first thrust, patterns of long-range coupling (or "communication") - both dynamic and thermodynamic - will be compared between the non-allosteric eglin c and the allosteric CheY. These comparisons will shed light on any basic differences in coupling networks between allosteric and non-allosteric proteins; they will also provide a test of the role of dynamics in mediating thermodynamic coupling. In the second thrust, the mechanism of intramolecular signal transduction in CheY will be investigated from an NMR dynamics perspective, using CheY's various biological states and mutations that modulate its activity. Overall, by increasing understanding of the biophysical properties and role of dynamics in allostery, this research will help to lay the foundation for the rational design of allosteric proteins and drugs. PUBLIC HEALTH RELEVANCE: Allosteric conformational change in proteins lies at the heart of regulatory processes such as cell division, metabolism, signal transduction, and drug action. This research seeks to understand the dynamic underpinnings of allostery by experimentally contrasting motional dynamics in non-allosteric and allosteric proteins. The small bacterial signal transduction protein CheY will serve as a model allosteric domain. A detailed understanding of allosteric mechanisms will be needed to rationally design proteins and drugs that take advantage of allosteric principles, as well as understand mechanisms of drug resistance.

描述（由适用提供）：蛋白质如何调节自身是生物学的基本问题。蛋白质活性的调节驱动细胞分裂，代谢，信号转导和热干预。最常见和多功能的调节蛋白是变构蛋白。变构蛋白的区别是它们在一个位点应对配体结合或化学修饰的能力，并改变不同位点的配体结合或活性。尽管许多变构蛋白在结构上得到了表征，并且存在变构模型，但有关变构转变的大多数细节仍未知。这项研究的远程目标是实验揭示构成变构功能的时间分辨结构过程。要采用的方法的核心是蛋白质是高度动态的，尤其是变构蛋白，而动态运动是变构构象变化的重要组成部分。经典的寡聚变构蛋白太大，无法通过NMR对位点特异性动力学进行深入研究。因此，单体14 kDa细菌反应调节剂Chey蛋白将用作模型变构域。 Chey是一种趋化信号转导蛋白，在ASP-57处的磷酸化后，在远端表面进行构象变化，该构象会调节与鞭毛运动的结合。在使用NMR弛豫方法的情况下，Chey的PS-NS和S-MS时间尺度动力学将在不存在和存在模拟磷酸组的情况下进行广泛表征。在单独的实验中，将使用高通量方法来映射远程热力学耦合。因为最近，在非功能变构的蛋白质中观察到了远距离通信，因此与变构蛋白相似的机制可能存在于非官方蛋白中，尽管在较小程度上。丝氨酸蛋白抑制剂Eglin C就是一个很好的例子：Eglin C中的保守突变导致在没有结构变化的情况下会产生远程动态效应。在拟议的研究中，四个特定目标属于两个主要推力。在第一个推力中，将比较非官方Eglin C和变构CHEY之间的远距离耦合（或“通信”）的模式（或“通信”）。这些比较将阐明变构和非官方蛋白之间耦合网络的任何基本差异。他们还将对动力学在介导热力学耦合中的作用进行测试。在第二个推力中，将利用Chey的各种生物学状态和调节其活性的突变来研究Chey中分子内信号转导的机制。总体而言，通过对生物物理特性和动力学在变构中的作用的了解，这项研究将有助于为变构蛋白和药物的合理设计奠定基础。公共卫生相关性：蛋白质的变构会议变化位于调节过程的核心，例如细胞分裂，代谢，信号转导和药物作用。这项研究旨在通过实验对比非官方和变构蛋白的运动动力学来理解变构的动态基础。小细菌信号转导蛋白Chey将用作模型变构域。对于利用变构原理的理性设计蛋白质和药物，需要对变构机制进行详细的理解，并了解耐药性的机制。